Zhu L - Search Results

1

[MDT Treatment of Small Cell Lung Cancer Complicated with Adenocarcinoma:  A Case Report and Literature Review].

Qu Z, Liu J, Luo F, Li L, Zhu L, Zhou Q. Qu Z, et al. Among authors: zhu l. Zhongguo Fei Ai Za Zhi. 2021 Nov 20;24(11):808-814. doi: 10.3779/j.issn.1009-3419.2021.102.37. Zhongguo Fei Ai Za Zhi. 2021. PMID: 34802214 Free PMC article. Review. Chinese.

2

Prognostic significance of nuclear Yes-associated protein 1 in patients with nonsmall cell lung cancer: A systematic review and meta-analysis.

Zhu L, Ma G, Liu J, Deng Y, Wu Q, Chen W, Zhou Q. Zhu L, et al. Medicine (Baltimore). 2019 Apr;98(16):e15069. doi: 10.1097/MD.0000000000015069. Medicine (Baltimore). 2019. PMID: 31008931 Free PMC article.

3

Sophoridine inhibits lung cancer cell growth and enhances cisplatin sensitivity through activation of the p53 and Hippo signaling pathways.

Zhu L, Huang S, Li J, Chen J, Yao Y, Li L, Guo H, Xiang X, Deng J, Xiong J. Zhu L, et al. Gene. 2020 Jun 5;742:144556. doi: 10.1016/j.gene.2020.144556. Epub 2020 Mar 9. Gene. 2020. PMID: 32165304

4

Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis.

Yu X, Zhu L, Liu J, Xie M, Chen J, Li J. Yu X, et al. Among authors: zhu l. Onco Targets Ther. 2020 Nov 13;13:11645-11658. doi: 10.2147/OTT.S271955. eCollection 2020. Onco Targets Ther. 2020. PMID: 33223838 Free PMC article. Review.

5

Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challenges.

Zhu L, Yu X, Wang L, Liu J, Qu Z, Zhang H, Li L, Chen J, Zhou Q. Zhu L, et al. Oncogenesis. 2021 Jul 10;10(7):47. doi: 10.1038/s41389-021-00335-w. Oncogenesis. 2021. PMID: 34247198 Free PMC article. Review.

6

A Comprehensive Understanding of Choroidal Metastasis from Lung Cancer.

Qu Z, Liu J, Zhu L, Zhou Q. Qu Z, et al. Among authors: zhu l. Onco Targets Ther. 2021 Aug 12;14:4451-4465. doi: 10.2147/OTT.S315532. eCollection 2021. Onco Targets Ther. 2021. PMID: 34408441 Free PMC article. Review.

7

Case Report: Anlotinib Reverses Nivolumab Resistance in Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma With FGFR3 Gene Amplification.

Liu Y, Long L, Liu J, Zhu L, Luo F. Liu Y, et al. Among authors: zhu l. Front Oncol. 2021 Oct 8;11:749682. doi: 10.3389/fonc.2021.749682. eCollection 2021. Front Oncol. 2021. PMID: 34692530 Free PMC article.

8

The developing landscape of combinatorial therapies of immune checkpoint blockade with DNA damage repair inhibitors for the treatment of breast and ovarian cancers.

Zhu L, Liu J, Chen J, Zhou Q. Zhu L, et al. J Hematol Oncol. 2021 Dec 20;14(1):206. doi: 10.1186/s13045-021-01218-8. J Hematol Oncol. 2021. PMID: 34930377 Free PMC article. Review.

9

Case Report: Partial Response Following Nivolumab Plus Docetaxel in a Patient With EGFR Exon 20 Deletion/Insertion (p.N771delinsGF) Mutant Lung Adenocarcinoma Transdifferentiated From Squamous Cell Carcinoma.

Zhu L, Liu Y, Gao H, Liu J, Zhou Q, Luo F. Zhu L, et al. Front Cell Dev Biol. 2022 Jan 10;9:755135. doi: 10.3389/fcell.2021.755135. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35083213 Free PMC article.

10

Identification of tumor microenvironment-based genes associated with acquired resistance to EGFR Tyrosine Kinase Inhibitor in Lung Adenocarcinoma.

Chen W, Li W, Liu Z, Ma G, Deng Y, Zhu L, Zhou Q. Chen W, et al. Among authors: zhu l. J Cancer. 2022 Jan 1;13(3):877-889. doi: 10.7150/jca.57008. eCollection 2022. J Cancer. 2022. PMID: 35154456 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30,132 results

Search Page

Filters